Compile Data Set for Download or QSAR
maximum 50k data
Found 437 with Last Name = 'long' and Initial = 'st'
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM19783((2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]...)
Affinity DataIC50:  0.0720nMpH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50084655(CHEMBL92708 | Calpeptin | Z-Leu-Nle-CHO | [(S)-1-(...)
Affinity DataIC50:  0.110nMAssay Description:Inhibitory activity against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Gsk

LigandPNGBDBM19783((2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]...)
Affinity DataIC50:  0.210nMAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138858(CHEMBL154579 | [(S)-1-(4-Phenyl-1H-pyrazol-3-ylami...)
Affinity DataIC50:  0.210nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138853(CHEMBL157072 | [(S)-1-(4-Bromo-1H-pyrazol-3-ylamin...)
Affinity DataIC50:  0.240nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138876(CHEMBL345569 | [(S)-1-(4-Fluoro-1H-indazol-3-ylami...)
Affinity DataIC50:  0.260nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50177501(CHEMBL203663 | {(S)-1-[(morpholine-4-carbonyl)-hyd...)
Affinity DataIC50:  0.330nMAssay Description:Inhibition of recombinant human cathepsin K in a fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50148292(((S)-1-Formyl-pentyl)-carbamic acid 1-benzyl-cyclo...)
Affinity DataIC50:  0.350nMAssay Description:Inhibition of recombinant human cathepsin K in a fluorescence assayMore data for this Ligand-Target Pair
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138866(CHEMBL156764 | [(S)-1-(1-Methyl-1H-pyrazol-3-ylami...)
Affinity DataIC50:  0.410nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179446((S)-4,4-dimethyl-2-oxo-1-((4-(trifluoromethyl)phen...)
Affinity DataIC50:  0.420nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138869(CHEMBL154959 | [(S)-1-(4-Methyl-1H-pyrazol-3-ylami...)
Affinity DataIC50:  0.470nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50148298(((S)-1-Formyl-pentyl)-carbamic acid (R)-1-benzyl-2...)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of recombinant human cathepsin K in a fluorescence assayMore data for this Ligand-Target Pair
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138879(CHEMBL345982 | [(S)-1-(5-Phenyl-1H-pyrazol-3-ylami...)
Affinity DataIC50:  0.650nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50139490(2,2,4,4-tetramethylpentan-3-yl(S)-1,2-dioxo-1-((R)...)
Affinity DataIC50:  0.710nMAssay Description:Inhibitory activity against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138871(CHEMBL154818 | [(S)-1-(5-Methyl-1H-pyrazol-3-ylami...)
Affinity DataIC50:  0.710nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138868(CHEMBL154862 | [(S)-1-(1H-Pyrazol-3-ylaminooxalyl)...)
Affinity DataIC50:  0.770nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50139481((R)-2,2-dimethyl-6-phenylhexan-3-yl(S)-1,2-dioxo-1...)
Affinity DataIC50:  0.790nMAssay Description:Inhibitory activity against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179439((S)-1-(benzo[d]thiazole-2-carbonyl)-4,4-dimethyl-2...)
Affinity DataIC50:  0.810nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50152524((S)-(1-(4-fluorobenzyl)cyclobutyl)methyl 1-(1H-pyr...)
Affinity DataIC50:  0.830nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138870(CHEMBL347004 | [(S)-1-(4-Cyano-1H-pyrazol-3-ylamin...)
Affinity DataIC50:  0.910nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50177494(CHEMBL204605 | {(S)-1-[(morpholine-4-carbonyl)-hyd...)
Affinity DataIC50:  0.940nMAssay Description:Inhibition of recombinant human cathepsin K in a fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179454((S)-4,4-dimethyl-2-oxo-1-(2-(trifluoromethyl)-1,3,...)
Affinity DataIC50:  1nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50139496((R)-4,4-dimethyl-1-phenylpentan-3-yl(S)-1,2-dioxo-...)
Affinity DataIC50:  1.10nMAssay Description:Inhibitory activity against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50139496((R)-4,4-dimethyl-1-phenylpentan-3-yl(S)-1,2-dioxo-...)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50177503(CHEMBL426308 | {(S)-1-[(2,3-dihydro-indole-1-carbo...)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of recombinant human cathepsin K in a fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM19793((2S)-1-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-3,3-...)
Affinity DataIC50:  1.40nMpH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179458((S)-1-(2-naphthoyl)-4,4-dimethyl-2-oxopyrrolidin-3...)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138846(3-[(S)-3-(1-Isopropyl-2-methyl-propoxycarbonylamin...)
Affinity DataIC50:  1.70nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179438((S)-1-(1H-indole-5-carbonyl)-4,4-dimethyl-2-oxopyr...)
Affinity DataIC50:  1.70nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Rattus norvegicus)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138858(CHEMBL154579 | [(S)-1-(4-Phenyl-1H-pyrazol-3-ylami...)
Affinity DataIC50:  1.80nMAssay Description:Inhibition of cystiene protease cathepsin K of ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50148296(((S)-1-Formyl-pentyl)-carbamic acid (S)-1-methyl-2...)
Affinity DataIC50:  1.80nMAssay Description:Inhibition of recombinant human cathepsin K in a fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM19796((2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]...)
Affinity DataIC50:  2.10nMpH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179445((S)-4,4-dimethyl-2-oxo-1-((4-(trifluoromethyl)phen...)
Affinity DataIC50:  2.10nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179437((S)-4,4-dimethyl-2-oxo-3-[(S)-1-((R)-1-phenyl-ethy...)
Affinity DataIC50:  2.10nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50165427(CHEMBL194068 | [(S)-1-((R)-1-Phenyl-ethylaminooxal...)
Affinity DataIC50:  2.5nMAssay Description:Inhibitory concentration against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138842(2,4-dimethylpentan-3-yl(S)-1,2-dioxo-1-((R)-1-phen...)
Affinity DataIC50:  2.5nMAssay Description:Inhibitory activity against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138842(2,4-dimethylpentan-3-yl(S)-1,2-dioxo-1-((R)-1-phen...)
Affinity DataIC50:  2.54nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179440((S)-1-(benzo[b]thiophene-2-carbonyl)-4,4-dimethyl-...)
Affinity DataIC50:  2.80nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50165424((S)-4,4-dimethyl-2-oxo-tetrahydrofuran-3-yl (S)-1,...)
Affinity DataIC50:  3nMAssay Description:Inhibitory concentration against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50165424((S)-4,4-dimethyl-2-oxo-tetrahydrofuran-3-yl (S)-1,...)
Affinity DataIC50:  3nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179442((S)-4,4-dimethyl-2-oxo-1-(2-phenylacetyl)pyrrolidi...)
Affinity DataIC50:  3nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM19794((2S)-1-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-3,3-...)
Affinity DataIC50:  3.20nMpH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM19791((2S)-3,3-dimethyl-1-[3-(pyridin-4-yl)-1H-pyrazol-1...)
Affinity DataIC50:  3.80nMpH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179453((S)-1-(benzylcarbamoyl)-4,4-dimethyl-2-oxopyrrolid...)
Affinity DataIC50:  3.80nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM19786((2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]...)
Affinity DataIC50:  4nMpH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179441((S)-4,4-dimethyl-2-oxo-1-(phenylcarbamoyl)pyrrolid...)
Affinity DataIC50:  4.30nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138864(CHEMBL351111 | [(S)-1-(Isoquinolin-3-ylaminooxalyl...)
Affinity DataIC50:  4.80nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50179435((S)-4,4-dimethyl-2-oxo-3-[(S)-1-((R)-1-phenyl-ethy...)
Affinity DataIC50:  5nMAssay Description:Inhibition of recombinant human cathepsin K by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Gsk

LigandPNGBDBM50138852(CHEMBL356378 | [(S)-1-(Isoxazol-3-ylaminooxalyl)-p...)
Affinity DataIC50:  5.10nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Gsk

LigandPNGBDBM50152524((S)-(1-(4-fluorobenzyl)cyclobutyl)methyl 1-(1H-pyr...)
Affinity DataIC50:  5.20nMAssay Description:Inhibition of 10 uM Cbz-Val-Val-Arg-AMC binding to human cathepsin S in fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 437 total ) | Next | Last >>
Jump to: